Federal Circuit Upholds Injunction Against NeoGenomics Over Alleged Patent Infringement

The Federal Circuit affirmed a preliminary injunction on Friday that prohibits NeoGenomics Laboratories Inc. from selling specific cancer tests. This decision comes as the North Carolina federal court continues to adjudicate allegations that these tests infringe upon patents held by Natera Inc. For further details, legal professionals can access the full information here.